Latest Islets of Langerhans Stories
Company Plans to Immediately Initiate Phase 1/2 Clinical Trial SAN DIEGO, Aug.
SAN DIEGO, Aug.
Destruction of insulin-producing beta cells in the pancreas is at the heart of type 1 and type 2 diabetes.
London, Ontario-based Sernova Corp., is developing a better way to treat the disease involving the replacement of lost pancreatic islets, whose function is to read blood sugar levels and release
Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted.
An innovative way to study glucose regulation in the body has been discovered by a research team from the Karolinska Institutet in Sweden. By transferring the vital insulin-producing cells from the pancreas to the eye, the team found that the eye can serve as a window through which health reports can be obtained from the pancreas.
An international team of researchers from the University of Copenhagen have successfully developed an innovative 3D method to grow miniature pancreas from progenitor cells.
Northwestern Medicine researchers have completed the first step toward animal-human transplants of insulin-producing cells for people with type-1 diabetes by successfully transplanting islets from one species to another.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.